The intracellular pathogen Burkholderia pseudomallei, which is endemic to parts of 6 southeast Asia and northern Australia, causes the disease melioidosis. Although acute infections 7 can be treated with antibiotics, melioidosis is difficult to cure, and some patients develop chronic 8 infections or a recrudescence of the disease months or years after treatment of the initial infection. 
Introduction

27
The intracellular pathogen Burkholderia pseudomallei, which causes the disease melioidosis, is 28 acquired from the environment in parts of southeast Asia and northern Australia [1, 2] . Although 29 acute infections can be treated with antibiotics, melioidosis is difficult to cure, requiring lengthy 30 treatment in two phases for a duration of ~20 weeks [3, 4] . Despite antibiotic therapy, some patients 31 have persistent cases that develop into chronic infections, and others experience a recrudescence of 2 of 33 compound biosynthesis [20] , branched chain amino acid biosynthesis [21] , purine metabolism [22] .
46
Other enzyme targets have been identified that are not in pathways -alanine racemase (interconverts L-and D-alanine) [23] , superoxide dismutase [24] and cyclic di-GMP phosphodiesterase [25] .
other, and the addition of the missing compound balanced the reaction. However, there were a small 121 number of reactions that could not be fixed and these were marked as unbalanced. Once all reactions 122 that could be fixed were corrected in the PGDB, MetaFlux was run again in development mode to 123 identify additional biomass metabolites, nutrients, and secretions. Once the set of biomass 124 metabolites was constant, the nutrients that could be consumed by the model were determined,
125
followed by identification of the secretions produced by the model. The result of this process was a 126 final unconstrained FBA model.
127
To mimic the nutrient conditions in culture, only the estimated set of ingredients present in LB 128 medium were included as nutrients in the FBA model. LB medium includes as its main ingredients 129 tryptone [40] and yeast extract [41] . Tryptone provides peptides and peptones, which are good 
269
Eight of the targets in Table 3 were also DrugBank targets in human; DrugBank was searched for the 270 remaining twenty-six targets, showing that they also occur in other bacteria.
271
In silico knockout experiments were performed with the MetaFlux module of Pathway Tools to 272 test the effect of inhibiting each chokepoint enzyme on B. pseudomallei growth in both the 273 unconstrained and LB media models. Results (Table 4) 
277
(murG) decreased the biomass flux in the unconstrained model, but did not eliminate it. 
359
With this large number of available genomes, a core genome approach [86, 87] could be used to identify potential metabolic enzyme targets that are present in all sequenced B. pseudomallei genomes.
361
In silico methods for the identification of therapeutic targets in bacterial pathogens include 362 comparative genomics-based approaches, such as identification of essential genes specific to the pathogen, and techniques based on metabolic pathway analysis and metabolic network modeling.
364
The 
437
The rest of the chokepoint enzymes in Table 3 
499
pseudomallei during infection, this model did not produce a solution so it was abandoned. However, 500 the LB media model contained a similar set of nutrients to those used by the intracellular pathogen
501
L. pneumophila [47, 48, 50] ,. so it may in fact be somewhat representative of infection conditions.
502
In silico knockout experiments were performed, where each chokepoint enzyme was knocked 503 out, one at a time, to assess the effect on the total flux through the unconstrained and LB media 504 models. Five chokepoint enzymes, when knocked out, had an effect on the models (Table 4) .
505
Specifically, knocking out BURPS668_3328 (tgt) and BURPS668_A2451 (leuB), eliminated the biomass 
527
In terms of carbon sources, glucose was utilized as a nutrient in the unconstrained model of B. 
564
Complicating the situation even more, the complete nutrient content of a representative 565 mammalian host cell cytosol has not been determined yet, so a consensus set of nutrients present in 566 the cytosol of different host cell types is still out of reach {Eisenreich, 2013 #40}. This is largely due to 567 the challenges in designing appropriate infection models and robust analytical approaches to 568 measure metabolic changes occurring in host cells during infection. Because of these limitations on 569 both the pathogen and host sides, it is difficult to predict which carbon sources pathogens can use to 570 grow inside host cells. While we don't know the exact biochemical composition of a mammalian cell 571 cytosol, we do know some details about mammalian cells in general. For example, the cytosol of a 572 typical cell has low magnesium, sodium and calcium concentrations, and a high potassium 573 concentration at neutral pH [195] . In addition, mammalian cells contain small amounts of amino 574 acids, plus significant amounts of TCA cycle intermediates [196, 197] 
